loadpatents
name:-0.0081660747528076
name:-0.00679612159729
name:-0.00052785873413086
Porter; Kevin R Patent Filings

Porter; Kevin R

Patent Applications and Registrations

Patent applications and USPTO patent grants for Porter; Kevin R.The latest application filed is for "psoralen-inactivated coronavirus vaccine and method of preparation".

Company Profile
0.5.7
  • Porter; Kevin R - Boyds MD
  • Porter; Kevin R. - Boyds MD US
  • Porter; Kevin R. - US
  • Porter, Kevin R. - Dallas TX
  • Porter; Kevin R. - Gaithersburg MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Psoralen-inactivated Coronavirus Vaccine And Method Of Preparation
App 20220168411 - Porter; Kevin R ;   et al.
2022-06-02
Induction Of An Immune Response Against Dengue Virus Using The Prime-boost Approach
App 20140271714 - Simmons; Monika ;   et al.
2014-09-18
Induction of an immune response against dengue virus using the prime-boost approach
Grant 8,440,202 - Simmons , et al. May 14, 2
2013-05-14
Induction of an immune response against dengue virus using the prime-boost approach
Grant 8,241,638 - Simmons , et al. August 14, 2
2012-08-14
Induction of an immune response against dengue virus using the prime-boost approach
App 20120135035 - Simmons; Monika ;   et al.
2012-05-31
Induction Of An Immune Response Against Dengue Virus Using The Prime-boost Approach
App 20120039937 - Simmons; Monika ;   et al.
2012-02-16
Method for the evaluation of dengue virus therapeutic agents
App 20080219930 - Burgess; Timothy H. ;   et al.
2008-09-11
Deploying service modules among service nodes distributed in an intelligent network
App 20050165906 - Deo, Ajay P. ;   et al.
2005-07-28
Dengue nucleic acid vaccines that induce neutralizing antibodies
Grant 6,455,509 - Kochel , et al. September 24, 2
2002-09-24
Recombinant dengue virus envelope protein/maltose-binding protein antigens and subunit vaccine compositions containing said antigens
Grant 5,895,651 - Simmons , et al. April 20, 1
1999-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed